Valuation: MedCap AB

Market Cap 8.28B 843M 755M 694M 629M 1.18B 80.04B 1.2B 3.32B 42.1B 3.16B 3.1B 133B P/E 2026 *
29.3x
P/E 2027 * 27.2x
Enterprise Value 8.45B 860M 770M 709M 642M 1.2B 81.68B 1.22B 3.39B 42.96B 3.23B 3.16B 135B EV / Sales 2026 *
3.56x
EV / Sales 2027 * 3.15x
Free-Float
88.3%
Yield 2026 *
-
Yield 2027 * -
1 day+2.88%
1 week-7.91%
1 month+5.53%
3 months+0.82%
6 months+15.26%
Current year+0.73%
1 week 535
Extreme 535
599
1 month 499.2
Extreme 499.2
604.5
Current year 440
Extreme 440
604.5
1 year 440
Extreme 440
607
3 years 271
Extreme 271
677
5 years 135
Extreme 135
677
10 years 27
Extreme 27
677
Manager TitleAgeSince
Chief Executive Officer 50 2020-10-31
Director of Finance/CFO 52 2020-04-29
Corporate Officer/Principal 54 2019-12-31
Director TitleAgeSince
Chairman 52 2007-12-31
Director/Board Member 63 2022-04-30
Director/Board Member 66 2022-04-30
Date Insider Type Main position Quantity % Market Cap. Importance
2/9/26 Buy 1,500 0.0099%
2/9/26
Anders Larnholt Forvaltning AB
SellCompany 1,500 0.0099%
2/6/26 Sell 500 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+2.88%-7.91%-9.05%+94.38% 843M
-2.44%+2.62%+5.98%+87.42% 177B
-1.18%+2.40%+27.69%+84.92% 146B
-1.51%+1.27%+36.30%+246.14% 98.99B
-1.73%+0.46%-19.18%+28.33% 94.78B
-0.62%+3.20%-15.05%+103.73% 87.79B
-1.49%+3.34%-20.23%+70.38% 84.73B
-0.68%+2.41%-11.07%+69.74% 77.24B
-2.29%+1.16%+46.78%+162.68% 46.19B
-1.42%-0.28%+8.41%+56.03% 42.61B
Average -1.05%+0.87%+5.06%+100.37% 85.64B
Weighted average by Cap. -1.54%+2.07%+6.42%+99.70%

Financials

2026 *2027 *
Net sales 2.38B 242M 217M 199M 181M 338M 22.97B 344M 954M 12.08B 908M 889M 38.1B 2.62B 266M 239M 219M 199M 372M 25.29B 379M 1.05B 13.3B 1B 978M 41.95B
Net income 282M 28.71M 25.71M 23.65M 21.43M 40.05M 2.73B 40.8M 113M 1.43B 108M 105M 4.52B 296M 30.18M 27.03M 24.86M 22.53M 42.11M 2.87B 42.9M 119M 1.51B 113M 111M 4.75B
Net Debt 169M 17.2M 15.41M 14.17M 12.84M 24M 1.63B 24.45M 67.84M 859M 64.56M 63.19M 2.71B -51M -5.19M -4.65M -4.28M -3.88M -7.24M -493M -7.38M -20.47M -259M -19.48M -19.07M -818M
Projected Income Statement - Annual - MedCap AB
Logo MedCap AB
MedCap AB (publ) is a Sweden-based private equity company engaged in investments in and development of companies active primarily within the medical equipment sector. The Company reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
Employees
663
Date Price Change Volume
26-10-30 SEK 553.00 +2.88% 16,496
26-10-29 SEK 537.50 -0.65% 13,238
26-10-28 SEK 541.00 -0.37% 18,486
26-10-27 SEK 543.00 -3.72% 32,539
26-10-26 SEK 564.00 -6.08% 45,929
Trader
-
Investor
Global
-
Quality
ESG MSCI
AAA
MarketScreener Ratings - MedCap AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
553.00SEK
Average target price
647.50SEK
Spread / Average Target
+17.09%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - MedCap AB
  1. Stock Market
  2. Stocks
  3. MCAP Stock